Free tool
Diagnostics stocks
We cover 4 companies grouped under the Diagnostics theme. The median market value in the group is $14.26B. Across the group, the median move over the past trading day is −0.31%. Price change over the past year runs from −14.1% to +38.2% across the middle 80 percent of the group, with a median of +15.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0KSX.L | Quest Diagnostics Incorporated | $27.60B | Large cap | +36.94% | Oct 20, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% | Oct 20, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% | Sep 10, 2026 |
| NIOX.L | NIOX Group Plc | $382.51M | Small cap | −6.05% | Sep 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.